|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Oct 4, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | |||||||||||
| Cash | |||||||||||
| Other current assets | |||||||||||
| Investments held in the Trust Account | |||||||||||
| Total Current Assets | |||||||||||
| Investments held in the Trust Account | |||||||||||
| Cash in transit to Trust Account | |||||||||||
| Total Assets | |||||||||||
| Current liabilities: | |||||||||||
| Promissory note – related party | |||||||||||
| Due to a related party | |||||||||||
| Promissory notes – a related party | |||||||||||
| Accrued expenses and other payable | |||||||||||
| Derivative Warrant Liability – Private Warrant | |||||||||||
| Deposit from the target company | |||||||||||
| Class A ordinary shares to be redeemed | |||||||||||
| Total Current Liabilities | |||||||||||
| Derivative warrant liability – private warrant | |||||||||||
| Deferred underwriting commission | |||||||||||
| Deferred underwriting commission | |||||||||||
| Total Liabilities | |||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 3,577,425 and 4,257,354 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | |||||||||||
| Class A Ordinary Shares | |||||||||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 3,577,425 and 4,257,354 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | |||||||||||
| Shareholders’ Deficit: | |||||||||||
| Ordinary shares, value | |||||||||||
| Class A Ordinary Shares | |||||||||||
| Class B Ordinary Shares | |||||||||||
| Total ordinary shares, value | |||||||||||
| Class B ordinary shares, $0.0001 par value, 50,000,000 shares authorized, 1,437,500 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Shareholders’ Deficit | |||||||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
